CTOs on the Move

Kolltan

www.kolltan.com

 
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.kolltan.com
  • 300 George St Ste 530
    New Haven, CT USA 06511
  • Phone: 203.773.3000

Executives

Name Title Contact Details

Similar Companies

Meridian Bioscience

EMSI Acquired Leprechaun

EMSI Acquired Leprechaun is a Fort Worth, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hospice of Central Michigan

Hospice of Central Michigan is a Mount Pleasant, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Family Care Spcalists Med Corp

Family Care Spcalists Med Corp is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Los Angeles, CA. To find more information about Family Care Spcalists Med Corp, please visit www.fcsmg.com

Conceptual Counseling Inc

Conceptual Counseling Inc is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.